Gavestinel

Gavestinel (GV-150,526) was an investigational drug developed by GlaxoSmithKline for acute intracerebral hemorrhage, which in 2001 failed to show an effect in what was at the time, the largest clinical trial in stroke that had been conducted.

Gavestinel is an NMDA antagonist, binding selectively to the glycine site on the NMDA receptor complex, rather than the glutamate site many NMDA antagonists bind to.

单词	Gavestinel
释义	Gavestinel 英语百科 Gavestinel Gavestinel (GV-150,526) was an investigational drug developed by GlaxoSmithKline for acute intracerebral hemorrhage, which in 2001 failed to show an effect in what was at the time, the largest clinical trial in stroke that had been conducted. Gavestinel is an NMDA antagonist, binding selectively to the glycine site on the NMDA receptor complex, rather than the glutamate site many NMDA antagonists bind to.
随便看	Antigens,CD88 Antigens,CD90 Antigens,CD95 Antigens,CD98 Antigens,CD98 Heavy Chain Antigens,CD98 Light Chains Antigens,CDw121a Antigens,CDw121b Antigens,CDw128a Antigens,CDw128b Antigens,CDw32 Antigens,Cell Surface Antigens,Class I Antigens,Class II Antigens,Deltaretrovirus Antigens,Dermatophagoides Antigens,Dermatophagoides farinae Antigens,Dermatophagoides pteronyssinus Antigens,Differentiation Antigens,Differentiation,B Lymphocyte Antigens,Differentiation,Myelomonocytic Antigens,Differentiation,T Lymphocyte Antigens,e antigen selection antigen selection hypothesis